Literature DB >> 24273023

Bisphosphonates beyond their anti-osteoclastic properties.

Massimo Varenna.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24273023     DOI: 10.1093/rheumatology/ket370

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  7 in total

1.  Evaluation of bone microstructure in CRPS-affected upper limbs by HR-pQCT.

Authors:  Haider Mussawy; Tobias Schmidt; Tim Rolvien; Wolfgang Rüther; Michael Amling
Journal:  Clin Cases Miner Bone Metab       Date:  2017-05-30

Review 2.  Bisphosphonates in the treatment of complex regional pain syndrome: is bone the main player at early stage of the disease?

Authors:  Massimo Varenna; Chiara Crotti
Journal:  Rheumatol Int       Date:  2018-07-14       Impact factor: 2.631

3.  Three-Component Reaction of Benzylamines, Diethyl Phosphite and Triethyl Orthoformate: Dependence of the Reaction Course on the Structural Features of the Substrates and Reaction Conditions.

Authors:  Patrycja Miszczyk; Ilona Turowska-Tyrk; Paweł Kafarski; Ewa Chmielewska
Journal:  Molecules       Date:  2017-03-11       Impact factor: 4.411

4.  In vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response.

Authors:  Rosangela Montanaro; Alessio D'Addona; Andrea Izzo; Carlo Ruosi; Vincenzo Brancaleone
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

Review 5.  Treatment of complex regional pain syndrome type I with bisphosphonates.

Authors:  Andrea Giusti; Gerolamo Bianchi
Journal:  RMD Open       Date:  2015-08-15

6.  Complex regional pain syndrome and bone marrow oedema syndrome: family ties potentially closer than expected.

Authors:  Samy Benchouk; Pierre-Alain Buchard; François Luthi
Journal:  BMJ Case Rep       Date:  2020-08-26

7.  Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study.

Authors:  Massimo Varenna; Vania Braga; Davide Gatti; Giovanni Iolascon; Bruno Frediani; Francesca Zucchi; Chiara Crotti; Fabrizio Nannipieri; Maurizio Rossini
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-06-11       Impact factor: 5.346

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.